Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Can/Fite
Recent news which mentions Can/Fite
Industry Analysts Seemingly Sing Praises For This Stock After Phase III Trial Results
July 14, 2022
Tickers
CANF
JNJ
MRK
PFE
Tags
Partner Content
PFE
Can/Fite
From
Benzinga
CANF: Beginning to Flex Its Muscles; Initiating With OUTPERFORM Rating, $6.00 Price Target
February 23, 2022
Tickers
CANF
Tags
General
Biotech
Market News
From
Benzinga
Piclidenoson Takes On Otezla, a $13 Billion Psoriasis Drug
December 14, 2021
Tickers
AMGN
CANF
CELG
PFE
Tags
PFE
Partner Content
Benzinga
From
Benzinga
Race to Effective Psoriasis Treatment: Can-Fite's Piclidenoson May Edge Over High-Flying Amgen's Otezla. Here's Why
October 20, 2021
Tags
General
Health Care
Can/Fite
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.